Publication of $MDNA 11 (IL-2) studyPublication of $MDNA 11 (IL-2) animal studies, incl non-human primates in the prestigious peer-revieed ASCO today.
Title: $MDNA 11 is a long-acting IL-2 superkine that potentiates durable immune response in mouse tumor models and non-human primates. (just google it to find abstract)
Just replicate these results in humans in ph1, and $MDNA is ready for prime-time stock performance.
Prelim results in about two months (December 2021)!
Any questions regarding relvance of non-human primates in immunological drug studies, refer to this research papaer by world-renowed immunotoxicologist Eberhard Buse entitled:
Development of the immune system in the cynomolgus monkey: the appropriate model in human targeted toxicology? (google it)
$nltx $nktr